Not Yet Recruiting NA INTERVENTIONAL 2-arm NCT07020429

Efficacy and Safety of Huanjingjian Decoction in Women With Premature Ovarian Insufficiency (EAST-HOPE)

Efficacy and Safety of the Traditional Chinese Herbal Formula Huanjingjian Decoction in Women With Premature Ovarian Insufficiency: a Randomised Controlled Trial

Sponsor: Jingan Hospital of Traditional Chinese Medicine

Conditions Premature Ovarian Insufficiency

Interventions Hormone replacement therapy Huanjingjian decoction Placebo

Updated 2 times since 2025 Last updated: Sep 1, 2025 Started: Sep 1, 2025 Primary completion: Jul 30, 2030 Completion: Jul 30, 2030

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Premature Ovarian Insufficiency and is currently actively recruiting participants. Jingan Hospital of Traditional Chinese Medicine leads this study, which shows 2 recorded versions since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

2 versions recorded

Oct 2025 — Present [monthly]

Not Yet Recruiting NA
Jul 2025 — Oct 2025 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jingan Hospital of Traditional Chinese Medicine
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai Geriatric Institute of Chinese Medicine
Shanghai Institute of Acupuncture and Anesthesia, Shanghai
Shanghai Pulmonary Hospital, Shanghai, China
Shanghai University of Traditional Chinese Medicine

Data source: Shanghai Pulmonary Hospital, Shanghai, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China